Correlation Between Medicofarma Biotech and Vercom SA
Can any of the company-specific risk be diversified away by investing in both Medicofarma Biotech and Vercom SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medicofarma Biotech and Vercom SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medicofarma Biotech SA and Vercom SA, you can compare the effects of market volatilities on Medicofarma Biotech and Vercom SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medicofarma Biotech with a short position of Vercom SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medicofarma Biotech and Vercom SA.
Diversification Opportunities for Medicofarma Biotech and Vercom SA
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Medicofarma and Vercom is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Medicofarma Biotech SA and Vercom SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vercom SA and Medicofarma Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medicofarma Biotech SA are associated (or correlated) with Vercom SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vercom SA has no effect on the direction of Medicofarma Biotech i.e., Medicofarma Biotech and Vercom SA go up and down completely randomly.
Pair Corralation between Medicofarma Biotech and Vercom SA
Assuming the 90 days trading horizon Medicofarma Biotech SA is expected to under-perform the Vercom SA. In addition to that, Medicofarma Biotech is 4.96 times more volatile than Vercom SA. It trades about -0.07 of its total potential returns per unit of risk. Vercom SA is currently generating about 0.05 per unit of volatility. If you would invest 11,900 in Vercom SA on November 28, 2024 and sell it today you would earn a total of 150.00 from holding Vercom SA or generate 1.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Medicofarma Biotech SA vs. Vercom SA
Performance |
| Timeline |
| Medicofarma Biotech |
| Vercom SA |
Medicofarma Biotech and Vercom SA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medicofarma Biotech and Vercom SA
The main advantage of trading using opposite Medicofarma Biotech and Vercom SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medicofarma Biotech position performs unexpectedly, Vercom SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vercom SA will offset losses from the drop in Vercom SA's long position.| Medicofarma Biotech vs. LSI Software SA | Medicofarma Biotech vs. Noble Financials SA | Medicofarma Biotech vs. PZ Cormay SA | Medicofarma Biotech vs. Centrum Finansowe Banku |
| Vercom SA vs. Varsav Game Studios | Vercom SA vs. MCI Management SA | Vercom SA vs. SOFTWARE MANSION SPOLKA | Vercom SA vs. Movie Games SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |